NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMS+) Q1 2023 Earnings

8MayExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
-1.8
-1.22
-0.65
-0.07

Details

Expected EPS
-0.4237
Actual EPS
-0.4351
Surprise EPS
-0.01
Surprise Percent
+2.69%

Description

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMS+) has reported earnings of -0.4351 per share for Q1 2023.

0 Comments

Share your thoughts